Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
NVCR · against 1,372 other Healthcare companies
Ranked #946 of 1,373 · scores higher than 31% of peers · safety percentile 31
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)137 peers with a safety percentile of 30–39, including NVCR · Click a bar to see the companies
Mainly because of its debt / equity and beta, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | NVCR | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 1,280 reported | 0.69× | 0.24× | 23% | 33% | |
| BetaLower is better · 1,320 reported | 1.01 | 0.53 | 24% | 33% | |
| Current ratioHigher is better · 1,338 reported | 2.89× | 2.62× | 54% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 186M USD | 100 | 52 | |
| 4 | 1.5B USD | 100 | 44 | |
| 5 | 1.2B USD | 100 | 40 | |
| 942 | 470M EUR (≈$517M) | 31 | 56 | |
| 943 | 231.7B JPY (≈$1.6B) |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 61 |
| 944 | 302.7B USD | 31 | 63 |
| 945 | 1.21T INR (≈$14.6B) | 31 | 55 |
| 946 | 1.6B USD | 31 | 30 |
| 947 | 1.2B USD | 31 |
| 948 | 35.2B JPY (≈$240M) | 31 | 12 |
| 949 | 24.7B CNY (≈$3.5B) | 31 | 39 |
| 950 | 354M USD | 31 | 13 |